Why now is a good time to rebalance your portfolio
Rebalancing your portfolio is a healthy financial habit. But it could be particularly important this year, says John Stepek.

When it comes to New Year’s resolutions, setting goals is old-fashioned. These days, say the productivity gurus, it’s all about developing good habits. One healthy financial habit to acquire, if you haven’t already, is the practice of rebalancing your portfolio at least once a year. Rebalancing is a simple concept. When you invest for the long term, you should have a plan in mind as to where you are going to put your money. This is known as “asset allocation”. It doesn’t have to be complicated – we generally suggest a division between stocks, bonds, property, gold and cash. Your precise asset allocation will depend on your time horizon and risk appetite (which in turn should mostly depend on your time horizon).
Of course, as time goes by, the percentage split of your portfolio will diverge from your initial asset allocation. If your equity holdings rise faster than your bonds, say, then you’ll end up with a bigger chunk of your money in stocks than you had originally planned, which theoretically means your portfolio has become riskier. The point of rebalancing is to bring it back into line when it has diverged sufficiently from your original plan.
Rebalancing won’t always result in a better performance than leaving your portfolio alone. But most studies (and logical intuition) suggest that in the long run there is a benefit in terms of reducing the risk of big drawdowns (ie, years where your portfolio loses a lot of money) without sacrificing much, if anything, by way of returns.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
The times they may be changing
Another good reason to rebalance is more specific to this year. We’ve gone through a lengthy period in which the gap between the returns on various asset classes and strategies has hit extreme levels. For example, commodities have gone through a long period of underperformance versus all other assets; value has been hammered relative to growth; and US markets have run well ahead of equity markets everywhere else.
That may continue – we don’t have a crystal ball. But there are signs of change. At a “big-picture” level, markets are starting to anticipate the return of inflation, particularly as higher US government spending seems likely if the Democrats do indeed take control of the Senate. This would imply a very different backdrop to the one we’ve seen over the past decade or so. If inflation returns, it implies that the assets which did best in the disinflationary post-financial crisis world – such as big tech stocks – will start to lag, while the sectors and assets that have struggled since then (including banks and gold) will benefit. So if you review your portfolio now and find that you are heavily exposed to the former, it might be a good time to take some profits and invest in the latter.
Sign up for MoneyWeek's newsletters
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
John Stepek is a senior reporter at Bloomberg News and a former editor of MoneyWeek magazine. He graduated from Strathclyde University with a degree in psychology in 1996 and has always been fascinated by the gap between the way the market works in theory and the way it works in practice, and by how our deep-rooted instincts work against our best interests as investors.
He started out in journalism by writing articles about the specific business challenges facing family firms. In 2003, he took a job on the finance desk of Teletext, where he spent two years covering the markets and breaking financial news.
His work has been published in Families in Business, Shares magazine, Spear's Magazine, The Sunday Times, and The Spectator among others. He has also appeared as an expert commentator on BBC Radio 4's Today programme, BBC Radio Scotland, Newsnight, Daily Politics and Bloomberg. His first book, on contrarian investing, The Sceptical Investor, was released in March 2019. You can follow John on Twitter at @john_stepek.
-
Barclays begins paying up to £100 compensation to customers after banking outage
Barclays will pay up to £7.5 million in compensation to customers after its banking services were disrupted by an IT outage
By Daniel Hilton Published
-
Review: Shangri-La Paris – an ode to the world’s best food
Natasha Langan enjoys fine French and Chinese cuisine at the Shangri-La Paris
By Natasha Langan Published
-
Falling revenues and mounting debt spell trouble for Jumia Technologies
Struggling African e-commerce platform Jumia Technologies looks headed for the exit, says Dr Matthew Partridge.
By Dr Matthew Partridge Published
-
Next reports £1 billion in annual profits for the first time – what's next for the retailer?
Clothing retailer Next has become only the fourth member of its sector to surpass £1 billion in annual profits. What does this mean for the company's future?
By Dr Matthew Partridge Published
-
Best of British bargains: cash in on undervalued companies in the UK stock market
Opinion Michael Field, Chief Equity Market Strategist, EMEA, Morningstar, selects three attractive UK stocks where he'd put his money
By Michael Field Published
-
Building firm Keller presents low debt and ample scope for growth
Geotechnical contractor Keller, which supports vital global infrastructure, boasts rising profits and a cheap valuation
By Dr Mike Tubbs Published
-
PZ Cussons share price down 75% in last decade – why it's one to watch
Opinion Once-strong consumer-goods business PZ Cussons is out of favour with the market. That spells opportunity for investors, says Jamie Ward
By Jamie Ward Published
-
Cash in on the biotech sector with specialist trust BioPharma
Opinion BioPharma has an attractive niche in lending to asset-rich biotechnology companies
By Rupert Hargreaves Published
-
India's stock market decline wipes out $1.3 trillion in market value – can investors stay optimistic?
More than $1 trillion has been wiped off from India's stock market after investors turn to China. Has the emerging-market darling hit rock bottom?
By Alex Rankine Published
-
Pensions revolution: how to profit from the trends shaping the UK pension system
The UK pension system is one of the biggest in the world. Big changes are under way, says Rupert Hargreaves
By Rupert Hargreaves Published